Abstract
Plasma-Derived C1 Inhibitor Concentrate Did Not Increase the Risk of Thromboembolism in Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency – a Long-Term Survey
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have